Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for IMDZF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IMDZF and 80,000+ other tickers.
See exactly how IMDZF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IMDZF and 80,000+ other tickers.
IMCD N.V. is a global leader specializing in the distribution and marketing of an extensive range of specialty chemicals and ingredients. The company serves a vast international market across Europe (including its home base in the Netherlands), the Middle East, Africa, North and South America, and the Asia-Pacific region. Its comprehensive portfolio caters to diverse industries, encompassing a wide array of specialized products. These include essential industrial chemicals like enzymes, surfactants, biocides, solvents, and functional additives. For life science sectors, IMCD provides crucial…
No recent news available.